The STEP UP trial, a Phase 3b study published in The Lancet Diabetes & Endocrinology in 2025, evaluated a 7.2 mg weekly injection dose in over 1,400 adults with obesity (BMI of 30 or higher) and without diabetes
Ashley Koff, RD 00:48:53 Tool, right
In the absence of published clinical data on these specific patches, consumers should approach claims about transdermal delivery of botanical extracts for metabolism or weight management with appropriate caution and ask manufacturers for evidence supporting their specific formulations
El futuro
Xu, I.M., et al.,Transketolase counteracts oxidative stress to drive cancer development
Standard glutathione is often destroyed during digestion, but liposomal delivery protects the nutrient to ensure it actually reaches your cells